#Ireland #Dublin #Healthcare Conference #Jazz Pharmaceuticals #BofA Securities

Jazz Pharmaceuticals to Engage at BofA Securities 2025 Healthcare Conference

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) has revealed its plans to join the esteemed BofA Securities 2025 Healthcare Conference. According to an official announcement made on April 30, 2025, the event will take place on May 14, featuring a prominent fireside chat conducted by management. This conversational format promises to provide insightful discussions about the company’s vision in the healthcare sector.

Event Details

The fireside chat is scheduled for 10:00 AM PT / 1:00 PM ET / 6:00 PM IST, offering a convenient opportunity for investors and stakeholders across various time zones to tune in. Interested parties can access an audio webcast of the session through the Investor section of Jazz Pharmaceuticals' official website at investor.jazzpharma.com. For those unable to attend the live event, a replay will be archived for 30 days, ensuring that the valuable insights shared during the session remain available for review.

About Jazz Pharmaceuticals

Founded with the mission to transform the lives of patients and their families, Jazz Pharmaceuticals has established itself as a global biopharma leader. The company is dedicated to developing innovative, life-changing medicines targeting serious diseases that often have limited treatment options. Its diverse portfolio includes cornerstone therapies addressing sleep disorders and epilepsy, alongside a rapidly expanding range of cancer treatments.

Headquartered in Dublin, Ireland, Jazz Pharmaceuticals boasts a robust pipeline of innovative therapeutics that spans across oncology and neuroscience. The company prides itself on a patient-focused approach, driven by scientific innovation. This devotion to research and development reinforces the company’s position in the global healthcare landscape.

With operations across various countries, Jazz Pharmaceuticals is committed to serving patients worldwide. This commitment is evident through its extensive network of research and development labs, manufacturing facilities, and a dedicated workforce.

Looking Ahead

The participation in the BofA Securities Healthcare Conference is a chance for Jazz Pharmaceuticals to showcase its progress and future plans in the realm of medical innovation. Investors, analysts, and healthcare professionals will likely gain enhanced understanding of the company's strategies and objectives as they relate to the broader industry landscape.

For ongoing updates about Jazz Pharmaceuticals and its initiatives, stakeholders are encouraged to visit the company’s website at jazzpharmaceuticals.com. The insights and discussions shared during the conference could very well set the stage for the company’s future endeavors and investor confidence.

As the healthcare market continues to evolve, Jazz Pharmaceuticals remains at the forefront of ensuring accessible, effective treatment options for those in need, as they strive to navigate the complexities of the pharmaceutical landscape.